Pharmabiz13m
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours: Redmond, Washington Monday, November 11, 2024, 14:00 Hrs [IST] SystImmune, Inc (SystImmune), a ...
Pharmabiz24m
Quantiphi and DDReg partner to transform regulatory reporting in life sciences through AI
Quantiphi, a global AI-first digital engineering company, and DDReg, a global leader in regulatory expertise, has inked a partnership that will address regulatory challenges that pharmaceutical ...
Pharmabiz6h
Ayush and herbal products exports grow over 10 per cent in H1 FY25
Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as ...
Pharmabiz1h
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...
Pharmabiz2h
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older
Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...
Pharmabiz1h
Health Vectors unveils Smart Health Report to spur future of personal health analytics
Health Vectors unveils Smart Health Report to spur future of personal health analytics: Our Bureau, Bengaluru Monday, November 11, 2024, 12:30 Hrs [IST] Health Vectors (HV), a hea ...
Pharmabiz1h
RPG Life Sciences appoints Ashok Nair as managing director (designate) following superannuation of Yugal Sikri
RPG Life Sciences has announced the appointed of Ashok Nair as managing director (designate) following superannuation of Yugal Sikri who served the company for six years. The company communication ...
Pharmabiz2h
Akums Drugs and Pharmaceuticals net profit doubles in Q2FY25
Akums Drugs and Pharmaceuticals has witnessed its net profit for the second quarter of the current fiscal year doubling to Rs. 66.65 crore from Rs. 32.69 crore registered during the same quarter last ...
Pharmabiz2h
Divis Laboratories net profit grew 47% in Q2FY25
Our Bureau, New Delhi Monday, November 11, 2024, 11:15 Hrs [IST] Hyderabad-based Divis Laboratories has registered a growth of 46 ...
Pharmabiz3h
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...
Pharmabiz4h
EMA’s veterinary committee issues first certificate for vaccine platform technology master file
EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...
Pharmabiz3h
Aurobindo Pharma net profit grows 8.6% in Q2FY25
Our Bureau, New Delhi Monday, November 11, 2024, 10:45 Hrs [IST] Hyderabad-based Aurobindo Pharma has registered a growth of 8.6 ...